Predictive Impact of MMP2 and MMP9 Levels for Patients With Metastatic Kidney Cancer Treated With Anti-angiogenic Agents
Clinical trial NCT03185039 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03185039
- Sponsor
- Institut Paoli-Calmettes
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-29
- Primary completion
- 2026-12-19
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.